Real-time enrollment status for this hematologic diseases clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 3:07 PM UTC
| NCT Number | NCT06222164 |
| Recruiting Status | Recruiting |
| Condition | Hematologic Diseases |
| Phase | Clinical Trial |
| Target Enrollment | 2,000 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Invivoscribe, Inc. |
| Last Updated on CT.gov | May 4, 2025 (May 4, 2025) |
As of July 19, 2026: Clinical trial NCT06222164 is currently recruiting participants. This clinical trial study for hematologic diseases is actively seeking new participants at 1 location across the United States. The study is sponsored by Invivoscribe, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06222164 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06222164 was last updated May 4, 2025 (May 4, 2025). HelloStudys verifies this status automatically.